Utilizing a liver-specific KLB knockdown mouse model, we further confirmed this association, highlighting the profound impact of KLB deficiency in limiting KD’s improvement of hepatic steatosis, suggesting the indispensability of the liver FGF21-KLB pathway. The gene discussed is KLB; the disease is fatty liver disease.